BRO

TentativeAI MemoPost-earnings T+3

Brown Brown

As of 2026-07-30/Post-earnings T+3/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-07-30 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Report quality notice

later post-earnings follow-up lacks concrete company-source and analyst/market reaction evidence

Action

—

Confidence

medium

Horizon

—

Key catalyst

Q2 earnings showed acquisition-led growth with weak underlying organic momentum • 2026-07-27

Base target: $76 / p=50% prob

Biggest risk

Organic revenue declined 0.7%, adjusted EBITDAC margin compressed 100 basis points year over year, and secondary coverage indicated slight revenue and adjusted-EPS misses versus consensus. The thesis remains dependent on acquisitions and contingent commissions offsetting softer core growth.

Invalidation

Break below $64 or thesis failure.

What would change my mind?

Reported revenue and adjusted EBITDAC growth remained strong, adjusted EPS increased year over year, and management described momentum entering the back half. Successful integration and renewed organic growth could support upside.

Research note

Recommendation

—

Confidence

medium

As of

2026-07-30

Base target

$76

p=50%

Bull target

$84

p=25%

Bear target

$64

p=25%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Post-print estimate and valuation reset
Organic growth reacceleration and acquisition integration in the second half
Reported revenue and adjusted EBITDAC growth remained strong, adjusted EPS increased year over year, and management described momentum entering the back half.

BearKey bullets

Contingent commissions and underwriting-linked revenue may be volatile.
Margin compression from acquisition amortization, integration costs, compensation, and interest expense.
Negative organic revenue growth and continued insurance-pricing or competitive pressure.

WatchKey bullets

Q2 earnings showed acquisition-led growth with weak underlying organic momentum

Summary

High-level snapshot

Recommendation

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Post-earnings T+3

Base case: $76 (p=50%)

Target spread vs base: +11% / -16%

Scenario probabilities

Bull Target: $84 (p=25%)Base Target: $76 (p=50%)Bear Target: $64 (p=25%)

Commentary

News tone is mixed: strong reported growth and management optimism were offset by organic softness, margin pressure, and a modest post-earnings consensus miss. Secondary coverage reported an initially negative premarket reaction followed by a recovery, while the July 29 packet anchor was $74.87. No verified post-print analyst target or estimate revision was available in the packet or narrow follow-up check. Social, options, short-interest, and employee-sentiment evidence is unavailable and should not drive the thesis.

As of 2026-07-30 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Post-print estimate and valuation reset
Organic growth reacceleration and acquisition integration in the second half

Scenarios

Bull Target (Scenario probability)

$84 / p=25% prob

Base Target (Scenario probability)

$76 / p=50% prob

Bear Target (Scenario probability)

$64 / p=25% prob

Analysis 2026-07-30 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

52.00

Social Sentiment (7d)

Events

Other notable items detected

EVENT2026-07-27
Q2 earnings showed acquisition-led growth with weak underlying organic momentum
The July 27 release reported revenue of $1.676 billion, up 30.4%, but organic revenue declined 0.7%; adjusted EPS was $1.07, up 3.9%. Management cited momentum into the back half of 2026. [#SEC-8K-2026-07-27] ([SEC Exhibit 99.1](https://www.sec.gov/Archives/edgar/data/79282/000119312526318245/bro-ex99_1.htm))
Prob 100.00% • Move 2.50% • Priced-in 85.00%

Short-term Catalysts

Next few weeks

Post-print estimate and valuation reset
2026-08-14
Secondary earnings coverage reported a modest miss versus consensus revenue of $1.72 billion and adjusted EPS of $1.08, creating near-term risk of estimate trimming despite a subsequent share-price recovery. ([Investing.com earnings coverage](https://www.investing.com/news/transcripts/earnings-call-transcript-brown--brown-misses-q2-2026-revenue-forecast-93CH-4816984))
Prob 60% • Move -3% • Priced-in 70%

Long-term Catalysts

Months to a year

Organic growth reacceleration and acquisition integration in the second half
2026-12-31
A durable bullish case requires organic revenue, organic revenue with contingents, and margins to improve after Q2 softness while acquisition benefits remain accretive. The company reported adjusted EBITDAC growth of 27.0% but adjusted margin declined to 35.7%. [#SEC-8K-2026-07-27]
Prob 55% • Move 10% • Priced-in 60%

Risks

Contingent commissions and underwriting-linked revenue may be volatile.
Margin compression from acquisition amortization, integration costs, compensation, and interest expense.
Negative organic revenue growth and continued insurance-pricing or competitive pressure.
Post-print analyst revision data remain thin, limiting confidence in the earnings follow-through.
Reported growth may remain acquisition-dependent, masking weak core operating momentum.
The current price is near the available analyst-target midpoint, limiting upside if organic growth does not reaccelerate.

Peers

Symbol	Summary
AJG	Direct insurance-brokerage comparator with a similar acquisition-oriented model, though larger scale and different specialty mix. ([peer comparison](https://www.financialcontent.com/quote/NY%3ABRO/competitors))
AON	Direct global insurance-brokerage comparator, but materially larger and more internationally diversified than BRO. ([peer comparison](https://www.financialcontent.com/quote/NY%3ABRO/competitors))
MRSH	Large global insurance-brokerage and risk-services comparator; useful for sector valuation and organic-growth context but not a close size match. ([peer comparison](https://www.financialcontent.com/quote/NY%3ABRO/competitors))
WTW	Direct brokerage and risk-advisory comparator with a broader consulting and benefits mix than BRO. ([peer comparison](https://www.financialcontent.com/quote/NY%3ABRO/competitors))

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-07-30

Loading AI feed…

Symbol

Summary

AJG

Direct insurance-brokerage comparator with a similar acquisition-oriented model, though larger scale and different specialty mix. ([peer comparison](https://www.financialcontent.com/quote/NY%3ABRO/competitors))

AON

Direct global insurance-brokerage comparator, but materially larger and more internationally diversified than BRO. ([peer comparison](https://www.financialcontent.com/quote/NY%3ABRO/competitors))

MRSH

Large global insurance-brokerage and risk-services comparator; useful for sector valuation and organic-growth context but not a close size match. ([peer comparison](https://www.financialcontent.com/quote/NY%3ABRO/competitors))

WTW

Direct brokerage and risk-advisory comparator with a broader consulting and benefits mix than BRO. ([peer comparison](https://www.financialcontent.com/quote/NY%3ABRO/competitors))